| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 6. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | losartan (Cozaar®) |
| Formulation | 2.5 mg/ml powder and solvent for oral suspension |
| Reference number | 370 |
| Indication | Treatment of essential hypertension in children and adolescents (aged 6 to 16 years) |
| Company | Merck Sharp & Dohme Ltd |
| BNF chapter | Cardiovascular system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 22/07/2009 |